There are some instances when you may need to suddenly stop taking the drug
If you have an intestinal obstruction, you may experience symptoms such as: Severe intestinal blockages may require surgery
See permissions for copyright questions and/or permission requests.
Patients given obeticholic acid showed improvement in fibrosis, hepatocellular ballooning, steatosis, lobular inflammation, the mean change in the NAFLD activity score (change from baseline=17 vs 07
Currently: Wegovy is FDA-approved for chronic weight management Zepbound is FDA-approved for chronic weight management in adults with obesity or overweight plus at least one weight-related condition Ozempic is FDA-approved for type 2 diabetes, not obesity From a patient perspective, FDA indication can affect insurance coverage, cost, and availability
One STEP-HFpEF trial analysis showed that patients with obesity-related HFpEF on semaglutide achieved cardiac remodeling benefits beyond the impact of weight loss
